Figure 1
From: Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report

Bruising on the external side of the left calf on the 11th day after the first natalizumab infusion.
From: Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
Bruising on the external side of the left calf on the 11th day after the first natalizumab infusion.